Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
CRISPR Therapeutics AG
*MAILING ADDRESS
Baarerstrasse 14
*CITY
ZUG V8 SWITZERLAND
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Switzerland
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
6300
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
aktiengesellschaft
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED
Switzerland
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular disease; gene therapy
products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular disease
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
042
*IDENTIFICATION
Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely,
pharmaceutical research and development
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Tiffany D. Gehrke
ATTORNEY DOCKET NUMBER
33324/60061
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Marshall, Gerstein & Borun LLP
INTERNAL ADDRESS
6300 Willis Tower
STREET
233 South Wacker Drive
CITY
Chicago
STATE
Illinois
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
60606
PHONE
312-474-6300
EMAIL ADDRESS
docket@marshallip.com
CORRESPONDENCE INFORMATION
NAME
Tiffany D. Gehrke
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
docket@marshallip.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
kkleinwachter@marshallip.com
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
2
APPLICATION FOR REGISTRATION PER CLASS
350
*TOTAL FEES DUE
700
*TOTAL FEES PAID
700
SIGNATURE INFORMATION
SIGNATURE
NOT PROVIDED
SIGNATORY'S NAME
NOT PROVIDED
SIGNATORY'S POSITION
NOT PROVIDED
DATE SIGNED
NOT PROVIDED
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:97461217
Filing Date:06/16/2022
To the Commissioner for Trademarks:
MARK: CTX310 (Standard Characters, see mark)
The literal element of the mark consists of CTX310. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, CRISPR Therapeutics AG, a aktiengesellschaft legally organized under the laws of Switzerland, having an address of
Baarerstrasse 14
ZUG V8 SWITZERLAND 6300
Switzerland
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular disease; gene therapy products, namely, gene
transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular disease
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 042: Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and
development
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Tiffany D. Gehrke. Tiffany D. Gehrke of Marshall, Gerstein & Borun LLP, is a member of the XX bar, admitted to the bar in XXXX, bar
membership no. XXX, is located at
6300 Willis Tower
233 South Wacker Drive
Chicago, Illinois 60606
United States
312-474-6300(phone)
docket@marshallip.com
The docket/reference number is 33324/60061.
Tiffany D. Gehrke submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).
Declaration
Declaration Signature
Signature: Not Provided Date: Not Provided
Signatory's Name: Not Provided
Signatory's Position: Not Provided
Signatory's Phone Number: Not Provided
Payment Sale Number: 97461217
Payment Accounting Date: 06/16/2022
Serial Number: 97461217
Internet Transmission Date: Thu Jun 16 10:19:29 ET 2022
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XXX-2022061610192983
9908-97461217-82007752c7293b6891c7e405a6
22192d73976164f6eb43cdd5a7db6f825394df7-
CC-19284006-20220616100810206826